CTICasesPleuroparenchymal Fibroelastosis (PPFE)
Imaging findings
Progressive apical fibrosis, traction bronchiectasis, and severe architectural distortion.
Key takeaways
Current clinical practice allows for the use of antifibrotic therapy in cases of progressive pulmonary fibrosis, regardless of whether it is strictly classified as Idiopathic Pulmonary Fibrosis (IPF) or PPFE.
AI-assisted summary — may contain errors. Verify against the source video. Learn more
More from this webinar
- Metastatic Pulmonary CalcificationMetabolic
- Airway AmyloidosisMetabolic
- Post-Transplant Lymphoproliferative Disorder (PTLD)Neoplastic
- Pulmonary Tuberculosis (TB)Infection
- Extensive NocardiosisInfection
- Superior Vena Cava (SVC) Syndrome and Venous EnhancementArtifact
- Silicosis and Progressive Massive Fibrosis (PMF)Exposure
- Recurrent Cystic Lung DiseaseAutoimmune
See all cases from August 14, 2025 →